← Back to Semaglutide

VS Peps · Certificate № JN-260515-0262

Certificate of Analysis

Compound identity

SMG

Semaglutide

Long-acting GLP-1 receptor agonist · 10mg lyophilized

Batch identifiers

Batch IDJN-260515-0262
Lab referenceLR-64454
Test date2026-05-15
Format10mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

99.6%

Area under the target peak as a percentage of total area.

Batch · 2026-05-15Janoshik Analytical · HPLC
99.6%SMG2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameSemaglutide
Editorial codeSMG
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

31residues
3-letter notation

31-residue peptide. Full sequence elided for readability — downloadable on the certificate of analysis.

Modifications

  • 01Aib at position 2
  • 02γ-Glu-C18 fatty acid sidechain at Lys-26

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 28 days. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-05-15

Document control

Certificate № JN-260515-0262Issued 2026-05-15Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.